About mckesson corp. - MCK
McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
MCK At a Glance
McKesson Corp.
6555 State Highway 161
Irving, Texas 75039
| Phone | 1-972-446-4800 | Revenue | 359.05B | |
| Industry | Medical Distributors | Net Income | 3.30B | |
| Sector | Distribution Services | 2025 Sales Growth | 16.216% | |
| Fiscal Year-end | 03 / 2026 | Employees | 45,000 | |
| View SEC Filings |
MCK Valuation
| P/E Current | 25.368 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 26.164 |
| Price to Sales Ratio | 0.24 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | 14.17 |
| Enterprise Value to EBITDA | 17.577 |
| Enterprise Value to Sales | 0.245 |
| Total Debt to Enterprise Value | 0.084 |
MCK Efficiency
| Revenue/Employee | 7,978,911.111 |
| Income Per Employee | 73,222.222 |
| Receivables Turnover | 14.002 |
| Total Asset Turnover | 5.036 |
MCK Liquidity
| Current Ratio | 0.899 |
| Quick Ratio | 0.526 |
| Cash Ratio | 0.097 |
MCK Profitability
| Gross Margin | 3.477 |
| Operating Margin | 1.218 |
| Pretax Margin | 1.214 |
| Net Margin | 0.918 |
| Return on Assets | 4.622 |
| Return on Equity | N/A |
| Return on Total Capital | 61.983 |
| Return on Invested Capital | 73.705 |
MCK Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 139.014 |
| Total Debt to Total Assets | 9.835 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 111.757 |
Mckesson Corp. in the News
Trump brings key prescription drug home to US in sweeping Walmart deal
The United States will increase amoxicillin manufacturing through a new deal between Walmart, McKesson and USAntibiotics, supporting Trump's domestic production goals.
West Virginia reaches $400 million settlement with opioid distributors
West Virginia reached a $400 million settlement on Monday with opioid distributors AmerisourceBergen Drug Co., Cardinal Health Inc., and McKesson Corp.
Pharmacy chain operator Giant Eagle settles Ohio opioid lawsuits mid-trial
Regional pharmacy chain operator Giant Eagle Inc on Friday said it had agreed to settle lawsuits accusing it of fueling the opioid epidemic in several Ohio communities,